[
    [
        {
            "time": "2023-10-25",
            "original_text": "What's in Store for Teladoc Health's (TDOC) Earnings in Q3?",
            "features": {
                "keywords": [
                    "Teladoc",
                    "Health",
                    "Earnings",
                    "Q3"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "What's in Store for Teladoc Health's (TDOC) Earnings in Q3?",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-25",
            "original_text": "Will Eli Lilly (LLY) Surpass Q3 Earnings Expectations?",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "LLY",
                    "Earnings",
                    "Q3",
                    "Expectations"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Will Eli Lilly (LLY) Surpass Q3 Earnings Expectations?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-25",
            "original_text": "Could This Be the Next Blockbuster Indication for Eli Lilly?",
            "features": {
                "keywords": [
                    "Blockbuster",
                    "Indication",
                    "Eli Lilly"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Could This Be the Next Blockbuster Indication for Eli Lilly?",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]